HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

Every morning, to avoid getting sick, Jessica Baudean must take a long trip across the Mississippi. Baudean, who is disabled, ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") ...